Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.26.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Summary of Significant Accounting Policies [Abstract]  
Schedule of Inventory Inventory that is in excess of current and projected use is reduced by an allowance to a level that approximates its estimate of future demand. Products that are determined to be obsolete are written down to net realizable value.
(dollars in thousands)   March 31,
2026
    December 31,
2025
 
Raw material   $ 23,033     $ 14,153  
Work in process     6,774       1,470  
Finished goods     5,470       7,992  
Less inventory reserves     (991 )     (1,652 )
Total inventory, net   $ 34,286     $ 21,963  
Schedule of Reconciliation of Basic to Diluted Shares

The reconciliation of basic to diluted shares is as follows (in thousands except share data):

 

    Three Months Ended
March 31,
 
    2026     2025  
Calculation of basic income (loss) per share attributable to stockholders            
Net income (loss) attributable to stockholders   $ 361,659     $ (15,343 )
Net income attributable to participating securities     (103,924 )    
-
 
Net income (loss) attributable to common stockholders - basic   $ 257,735     $ (15,343 )
Weighted-average common shares outstanding – basic     445,088,835       105,004,818  
Earnings per share - basic   $ 0.58     $ (0.15 )
Calculation of diluted income (loss) per share attributable to stockholders                
Net income (loss) attributable to stockholders   $ 361,959     $ (15,343 )
Net income attributable to participating securities     (103,924 )    
-
 
Net income (loss) attributable to common stockholders - diluted   $ 257,735     $ (15,343 )
                 
Weighted-average common shares outstanding – basic     445,088,835       105,004,818  
Common stock warrants     278,260      
-
 
Common stock options     10,012,986      
-
 
Restricted stock units     6,308,924      
-
 
Other     16,951      
-
 
Weighted-average common shares outstanding – diluted     461,705,956       105,004,818  
Net income (loss) per share - diluted   $ 0.56     $ (0.15 )
Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share

The following potentially dilutive securities for the three months ended March 31, 2026 and 2025, have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.

 

    Three Months Ended
March 31,
 
    2026     2025  
Warrants to purchase common stock     195,527,101       25,384,610  
Options to purchase common stock     654,350       9,349,311  
Contingently issuable shares     109,456,221      
-
 
Potential shares issuable under 2022 Convertible Promissory Notes    
-
      19,502,416  
Potential shares issuable under 2023 Additional Notes    
-
      30,237,267  
Potential shares issuable under 2024 Additional Notes    
-
      42,348,142  
Restricted stock units    
-
      1,458,600  
Total potentially dilutive securities     305,637,672       128,280,346